Copyright
©The Author(s) 2025.
World J Gastrointest Endosc. Jan 16, 2025; 17(1): 97840
Published online Jan 16, 2025. doi: 10.4253/wjge.v17.i1.97840
Published online Jan 16, 2025. doi: 10.4253/wjge.v17.i1.97840
Table 1 Baseline characteristics of the existing and novel catheter groups, n (%)
| Character | Existing catheter group (n = 230) | Novel catheter group (n = 112) | P value |
| Age median (range) | 77 (29-97) | 80.5 (44-104) | 0.84 |
| Sex (male/female) | 144/96 | 56/56 | 0.874 |
| Primary disease | |||
| Benign disease | 147 (63.9) | 73 (65.1) | - |
| Bile duct stones | 134 (58.2) | 66 (58.9) | - |
| Benign bile duct stricture | 6 (2.6) | 2 (1.8) | - |
| Other (benign) | 7 (3.0) | 5 (4.5) | - |
| Malignant disease | 83 (36.1) | 39 (34.8) | - |
| Pancreatic cancer | 33 (14.3) | 16 (14.2) | - |
| Cholangiocarcinoma | 46 (20.0) | 22 (19.6) | - |
| Other (malignant) | 4 (1.7) | 1 (0.9) | - |
| Benign/malignant disease | 147/83 | 73/39 | 0.90 |
| Parapapillary diverticular papilla | 60 (26.1) | 27 (24.1) | 0.79 |
| Oral protrusion-large | 60 (26.1) | 28 (25.0) | 0.90 |
| Expert/non-expert | 115/115 | 64/48 | 0.25 |
- Citation: Kaneko T, Kida M, Kurosu T, Kitahara G, Koyama S, Nomura N, Tahara K, Kusano C. Outcomes of bile duct cannulation using a novel contrast-enhanced catheter: A single-center, retrospective cohort study. World J Gastrointest Endosc 2025; 17(1): 97840
- URL: https://www.wjgnet.com/1948-5190/full/v17/i1/97840.htm
- DOI: https://dx.doi.org/10.4253/wjge.v17.i1.97840